Valion Bio Operating Margin Growth & History (VBIO)

Valion Bio's operating margin was −573.85% for fiscal 2024.

View full Valion Bio company overview

Valion Bio annual operating margin history

Valion Bio annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20242024-12-31−573.85%+127.26 pp
20232023-12-31−701.11%−152.30 pp
20222022-12-31−548.80%−100.67 pp
20212021-12-31−448.13%

Valion Bio operating margin trends

Across the available reported history, Valion Bio's operating margin increased from −701.11% to −573.85%, a change of +127.26 percentage points. The latest reported quarter, Q3 2025, shows −1,700.68%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Valion Bio filings at SEC.gov ↗